- Research
- Open access
- Published:
Impact of airborne particulate matter exposure on hospital admission for Alzheimer's disease and the attributable economic burden: evidence from a time-series study in Sichuan, China
Environmental Sciences Europe volume 36, Article number: 12 (2024)
Abstract
Background
Alzheimer's disease (AD) and other forms of dementia are the seventh leading cause of death. Studies discern the inclusion of air pollution among modifiable risk factors for dementia, while limited studies are for China. This study aims to examine the short-term association between airborne particulate matter (PM) and the hospitalizations of AD, including the economic costs in China.
Methods
A total of 4975 cases of AD patients hospitalized from 2017 to 2019, were collected from nine city and 411 medical institutions in Sichuan Province, China. Data on air pollutants such as PM2.5, PM10, and NO2 were obtained from 183 air quality monitoring stations in Sichuan Province. A time series-generalized additive model was used to estimate the association between short-term exposure to PM (lag1–lag7 and moving average lag01–lag07) and AD hospital admissions (HAs), stratified by gender, age, and season.
Results
Positive short-term exposure to airborne PM was found for the HAs of AD. The greatest effect on the number of AD inpatients was on single-day lag1 (PM2.5:1.034 (95% confidence interval (CI) 1.011, 1.058)). The association was also significant in the two-pollutant model. In the study period, 16.48% of AD HAs were attributed to the effect of PM. The total economic costs of AD attributable to PM exposure were US$ 2.56 million, including US$ 2.25 million of direct medical costs and US$ 0.31 million of indirect economic costs.
Conclusions
This study suggests that short-term exposure to airborne PM may increase the risk of AD HAs in Sichuan Province and result in associated economic costs.
Introduction
Alzheimer's disease (AD) has an insidious onset and is a progressive, irreversible neurodegenerative disease affecting cognition, function, and behavior [1]. As the most common cause of dementia, it accounts for 60–70% of all dementia cases [2]. According to the World Health Organization (WHO) report 2021, the population with AD and other forms of dementia is expected to rise to 78 million by 2030 and to 139 million by 2050 [3]. China has the largest population of AD patients in the world [4], and the number will continue to increase with extended life expectancy and population aging. A recent study has indicated that 9.83 million people aged 60 years and older in China have AD [5], and the number is expected to increase to over 16 million by 2030 [6]. AD and other dementia are currently the seventh leading cause of death in the world, and also are among the top 10 causes of disability-adjusted life years (DALYs) occurring in people aged 75 years and older [7]. At present, AD has become the fifth leading cause of death for urban and rural residents in China [8], and is listed as one of the "four killers" threatening the health of the elderly, posing a huge challenge to social and economic development.
The global cost of AD and other dementia is about $1 trillion per year [9]. It is estimated that these costs will increase to 1.7 trillion USD by 2030 [3]. Researchers have predicted that the economic burden of disease attributable to AD in China will increase from 91 billion yuan in 2010 to 332 billion yuan in 2050 [10]. However, the current rate of AD diagnosis and treatment is low compared to its high prevalence [11], meaning that the actual number of AD patients is probably much higher. Meanwhile, there is still no treatment that can alter the progression of AD [12]. Therefore, it is necessary to employ effective prevention and control strategies to address the potential risk factors, reduce the number of AD patients, improve their life quality, and thus alleviate the associated social and economic burden.
AD has a wide range of etiologies, and notably, there is growing evidence for association between AD and air pollution. Livingston et al. included air pollution as one of the new modifiable risk factors [9]. Scientific evidence from experimental studies suggests that acute particulate matter exposure typically has two pathways to brain. A fraction of particles that deposit in the nose (nasal deposition) can reach the brain via uptake over the nasal epithelium and retrograde axonal transport along the olfactory nerve. The other is that deposited in the lower respiratory tract (alveolar deposition) can translocate from the alveoli into the blood and subsequently over the blood–brain barrier into the brain. Then this process is associated with the development of AD through mechanisms such as oxidative stress, mitochondrial dysfunction, microglia activation and neuroinflammation, accelerating emergency hospital admissions for normal person or AD patients through these pathways [13,14,15,16]. At present, many studies worldwide have analyzed the relationship between long-term exposure to airborne PM and the incidence of AD. Studies in several countries [17, 18] and multiple regions of China1 [19,20,21] have confirmed that long-term exposure to PM2.5 and PM10 increases the risk of AD. However, evidence for a short-term association between AD hospitalizations and particulate matter remains limited. In Madrid, a time-series study found that short-term exposure to PM2.5 was associated with emergency hospitalizations for AD with a relative risk (RR) of 1.38 (95% confidence interval (95% CI) 1.15, 1.65) [22]. An ecological study from an aged European metropolis also reported that short-term exposure to PM2.5 was associated with emergency hospital admissions for AD, reporting that for each 10 μg/m3 increase in PM2.5 concentrations is linked with the increasing rate of AD admission by 3.75% (95% CI 1.91,5.63) [23]. The above studies justify the plausibility of testing the short-term effects of air pollution on the occurrence of Alzheimer's disease in humans. Therefore, more research is urgently needed to explore whether short-term exposure to PM increases the risk of AD.
Sichuan Province, located in southwestern China, consists of the Sichuan Basin (SCB) and the Western Sichuan Plateau. Highly industrialized and/or urbanized cities in the basins and mountains often experience severe air pollution; thus, the SCB is also known as one of the four most polluted areas in China [24]. The complex topography forms a unique weather system in the region [25, 26], which, coupled with accelerated urbanization and industrialization, results in the severe PM pollution in the SCB region. Therefore, a time-series design was applied in this study to explore the association between short-term exposure to airborne PM and the number of AD inpatients based on statistics of AD hospital admission (HAs) from January 1, 2017, to December 31, 2019, collected from 411 medical institutions in Sichuan Province, China, and to estimate the economic loss of disease attributable to airborne PM exposure.
Material and methods
Study population
This study collected the residential addresses, dates of admission and discharge, hospital charges, and disease diagnoses of AD-related inpatient cases from January 1, 2017, to December 31, 2019, in nine cities in Sichuan Province, namely, Chengdu, Guang'an, Luzhou, Mianyang, Meishan, Nanchong, Yibin, Zigong, and Liangshan Yi Autonomous Prefecture. Among them, Liangshan Yi Autonomous Prefecture is located in the Western Sichuan Plateau, while the other eight cities are located in the SCB. The International Classification of Diseases, tenth edition code (ICD-10) G30 was used to identify the AD cases diagnosed in 2017–2019, and a total of 411 hospitals and 4975 AD patients were covered after excluding cases with missing residential addresses.
Environment data
Based on the residential addresses of cases in the database, latitude and longitude were matched using the Gaode Map Application Programming Interface (API) and R software version 4.1.2 (https://lbs.amap.com/). The daily mean data on the concentrations of air pollutants (PM2.5, PM10, CO, SO2, NO2, and O3) from January 1, 2017, to December 31, 2019, were obtained from 183 air quality monitoring stations in Sichuan Province. To adjust the effect of meteorological factors on the number of AD inpatients, meteorological data on average daily temperature and relative humidity were also collected. The geographical locations of the air quality monitoring stations and hospitals involved in this study are shown in Fig. 1.
Statistical analysis
Effects of air pollutants on AD HAs
Based on the number of days of HAs and monitoring station data for each AD case, the inverse distance (1/d2) weighted average of concentration at all monitoring stations was used to estimate air pollutant exposure on the day of HAs (lag0) [27]. The day of the AD-related HAs was defined as lag0, with the day before the episode being defined as lag1, and so on. Single-day lagged exposures (lag1–lag7) and moving average daily lagged exposures (lag01–lag07) were identified as time windows to estimate the immediate, delayed, or extended effects of pollutants [28]. Since the daily number of hospitalizations for AD usually obeys an over-dispersed Poisson distribution, a quasi-Poisson generalized additive model (GAM) was adopted in this study [29, 30]. This study analyzed the associations between the two air pollutants (PM2.5, PM10) and the daily average number of hospitalized for AD with single-day lags from the current day (lag0) and each 1–7 days and moving average exposure of multiple days (lag01–lag07). In the GAM model, a smoothing spline function was selected to control the confounding effects of the long-term trend and meteorological factors (on average daily temperature and relative humidity). Its lag effect is the same as that of air pollutants, yielding the following equation:
where E (Yi) is the expected number of hospitalized for AD on day i; α stands for the model intercept; Zi represents the air pollutant concentration on dayi (μg/m3); β represents the exposure–response coefficient, which is the increase in the number of daily hospitalizations caused by the per unit increase in pollutant concentration; s is a non-smooth parameter item; and df is the degree of freedom. The time stands for a date variable with a degree of freedom of 7/year; as.factor is a join function, which is to convert the factor vector into a string vector using the as factor function; dow is an indicator variable of “day of the week”; temperature and humidity stand for the average daily temperature and relative humidity, whose degrees of freedom are both 4.
RR represents the risk of AD HAs for each 10 μg/m3 increase in the concentrations of PM2.5 and PM10, and the 95% CI represents its significance [31]. The equations are as follows:
Subgroup analysis was performed in the second stage. Considering that age is the greatest risk factor for AD and a fundamental driver of AD development [32]; complex interaction between AD and gender [33]; and extremely low and high temperatures may exacerbate PM-related mortality/incidence [34]. This study performed stratified analyses according to age (< 75, 75–85, ≥ 85), gender (male and female), and season (warm season: April–September, cool season: October–March) subgroups, and z tests were used to estimate statistical differences in the stratified analysis [35]. The statistical significance of differences between effect modifiers (e.g., between cool and warm seasons) was tested by calculating the 95% CI with the following equation:
where \(\stackrel{\wedge }{{Q}_{1}}\) and \(\stackrel{\wedge }{{Q}_{2}}\) are the adjusted estimated values for different categories in each stratified subgroup (e.g., cool and warm seasons) and \(S\stackrel{\wedge }{{E}_{1}}\) and \(S\stackrel{\wedge }{{E}_{2}}\) are the respective standard errors [36, 37].
Calculation of number of AD HAs and economic loss of AD attributable to exposure to air pollution
Based on the exposure–response coefficients obtained from the R "mgcv" package, the number of AD inpatients [38] and economic costs of disease [37, 39] attributable to airborne PM exposure were further calculated using the attributable risk method. The 24-h mean concentrations were determined as the reference pollutant concentrations (15 μg/m3 for PM2.5 and 45 μg/m3 for PM10) based on the WHO AQGs 2021 [40]. The coefficient βs is the sum of the coefficients of the days affecting significant lags [39, 41]. The indirect economic burden attributable to AD HAs was estimated using the per capita daily disposable income in Sichuan Province [31]. The economic burden was calculated according to the following equations:
where i denotes the number of days in the study period (from 1 to 1095), j represents the air pollutants PM10 and PM2.5, ARij is attributable risk, ΔAPi is the difference between the observed pollutant concentration on day i and the reference concentration, Ni is the number of AD inpatients on day i, and AN is the total number of AD inpatients due to air pollution, DC is the direct medical costs of HAs caused by air pollution, Costtotal is the average direct medical costs per HA case during the study period, IC is the indirect economic costs attributable to air pollution, Hd denotes the average number of days of HA per case, and dPCDI is the per capita daily disposable income in Sichuan Province.
Sensitivity analysis
Two types of sensitivity analyses were performed to verify the stability of the model. First, the stability of the time trend was tested, and the model was fitted by changing the degree of freedom of the time-series (df = 5, 6, 8, 9 per year). Second, a sensitivity analysis was performed on cases within a 50-km circular area of the air monitoring stations to assess the robustness of these results. Data from AD inpatients residing outside the 50-km radius of the nearest air monitoring station were excluded to reduce bias due to spatial variability of pollutant measurements [42]. Nearest neighbor analysis was performed using the "Distance to nearest hub" and "Distance matrix" toolkits in QGIS software.
Results
Study population
As shown in Table 1, a total of 4975 AD patients were included in this study during the 3-year period from 2017 to 2019. Among them, there were slightly more female patients than male patients, with 2299 (43.21%) being male and 2676 (53.79%) being female. Regarding their locations, 99.52% of AD patients resided in the SCB. Meanwhile, AD inpatients were predominantly elderly patients ≥ 85 years old (1853, 37.25%). In addition, there were slightly more AD inpatients in the warm season (2557, 51.40%) than in the cold season (2418, 48.60%).
Data description of air pollution and meteorological factors
As shown in Table 2, the daily average concentrations (\(\overline{x }\pm s\)) of pollutant exposure in AD patients during the study period were as follows: 45.12 ± 32.37 μg/m3 for PM2.5, 69.85 ± 43.68 μg/m3 for PM10, 0.78 ± 0.27 mg/m3 for CO, 10.09 ± 4.78 μg/m3 for SO2, 33.36 ± 17.45 μg/m3 for NO2, and 84.03 ± 44.30 μg/m3 for O3. The daily average temperature was 17.44 ℃, and the relative humidity was 77.71%.
Health effects of PM pollution on overall and subgroup populations
Figure 2 presents the single-pollutant models on different lag days, indicating a positive association between PM2.5 exposure (every 10-μg/m3 increase in airborne PM concentration) and AD HAs. The association between PM2.5 and AD was statistically significant on single-day lag 0–1 and moving average lag days (lag01–lag03). However, the difference between PM10 and AD was not statistically significant for single-day lag and moving mean lag days. PM2.5 had the greatest effect on the number of AD inpatients on lag1 with the RR values being 1.034 (95% CI 1.011,1.058).
Figure 3 analyzes the effects of each 10-µg/m3 increase in PM2.5 and PM10 concentrations on AD in different gender, age, and season groups on lag0, lag1, and lag01 after adjusting temperature and relative humidity. Regarding the gender subgroups, the effects of PM2.5 and PM10 exposure were significant on both male and female populations, but the difference between the genders was not statistically significant (p > 0.05). As for the different age groups, on lag0 and lag01, the effects of PM2.5 and PM10 were not significant for those aged 75–85 years, but people aged 85 years and above were more sensitive to PM2.5 and PM10 exposure; however, none of the differences between different age groups was statistically significant (p > 0.05). On lag1, the effects of PM2.5 exposure were found to be positive and significant for all age groups, but none of the differences between different age groups was statistically significant (p > 0.05). As for their effects in different seasons, on lag0, lag1, and lag01, PM2.5 had positive and significant effects on AD HAs in the cold season, but the difference between the cold and warm seasons was not statistically significant (p > 0.05). (Additional file 1: Tables S1, S2).
According to Table 3, there may be an independent relationship between PM2.5 in the air and AD HAs risk. Upon introducing SO2, NO2, and O3 in the two-pollutant model for adjustment, the association between PM2.5 and AD remained significant and the effect size increased slightly. For example, the AD risk went up from 3.5% (95% CI 1.011, 1.058) to 4.1% (95% CI 1.015,1.069) for each 10-μg/m3 increase in PM2.5 after the introduction of NO2 to the PM2.5 model. Similarly, as a result of the introduction of SO2 to the PM2.5 model, the AD risk went up from 3.5% (95% CI 1.011, 1.058) to 4.2% (95% CI 1.017,1.068).
Table 4 shows the attributable number (AN), attributable risk (AR), and economic burden of disease of AD HAs caused by exposure to PM2.5 in Sichuan Province from 2017 to 2019, with the WHO air quality standards as reference concentrations. After adjusting for other pollutants, the effect of PM2.5 pollution on AD remained significant. During the study period, the number of AD inpatients attributable to PM2.5 pollution was 820. In this study, the per capita disposable income of Sichuan Province from 2017 to 2019 (US$2995.63, US$3269.37, US$3595.80) was obtained from the Statistical Yearbook of Sichuan Province. Further calculate the per capita daily disposable income of Sichuan residents during the study period (US$ 9.01). The associated economic costs totaled US$ 2.56 million. The direct disease economic burden from PM2.5 is US$ 2.25 million (87.83%).
Sensitivity analysis
In the sensitivity analysis, the acute impact of PM on the hospitalizations with AD not change substantially after replacing the annual degree of freedom of the time-series (df) with 5, 6, 8 and 9 (Additional file 1: Table S3). Second, data from 239 AD inpatients residing outside the 50-km radius of the nearest air monitoring station were excluded, and the relationship between PM exposure and AD was then reanalyzed. Compared with the results of the original models before sensitivity analysis, the results obtained showed no significant difference. The estimated effects of PM2.5 still remained at the maximum levels on lag1. The RR values for PM2.5 was 1.034 (95% CI 1.011, 1.058) before lag1 adjustment and 1.032 (95% CI 1.009, 1.056) after adjustment, indicating that the main model is robust overall (Additional file 1: Table S4).
Discussion
Our study found that short-term exposure to airborne PM was significantly associated with the number of AD inpatients. In single-pollutant models, PM2.5 was positively associated with AD HAs. Although the possible mechanisms underlying the relationship between short-term exposure to particulate matter and the risk of AD hospitalization have not been fully elucidated, current toxicological studies have provided some clues to the underlying biological mechanisms. Short-term exposure to environmental particulate matter can induce or enhance biological processes in the brain, such as oxidative stress and neuroinflammation. Oxidative stress induced by PM could initiate neurotoxicity or enhance pre-existing (e.g., Aβ-induced) pathology and thus form a vicious cycle that promotes the initiation and progression of AD [43]. And there is evidence that neuroinflammation can precipitate AD. In a study of the World Trade Center exposed responders found that acute high exposure to particulate matter, particulate matter may infiltrate directly into the brain, and induce neuroinflammation via the neural infiltrate model leading to cognitive impairment, which may be similar to the hallmarks of Alzheimer's disease and related dementias [16]. Similar to our findings, a recent US study also discovered that Medicare beneficiaries with AD were at higher risk of AD after acute exposure to PM; they may be more sensitive to air pollution-related inpatient treatment and more susceptible to neuroinflammation caused by the deleterious effects of PM2.5 [44]. In addition, there is substantial evidence that short-term exposure to particulate matter activates microglia (a classic pathological feature of AD) [45, 46]. When activated microglia are further activated by subsequent systemic infections, this leads to significantly elevated levels of the acute phase cytokine interleukin 1β in the CNS and ultimately leads to the occurrence of AD [47]. Similarly, short-term exposure to particulate matter induced systemic inflammation triggers regulatory pathways activated by microglia and astrocytes in the brain, and this microglial over-response to systemic inflammation is observed in animal models of normal aging and neurodegeneration, as well as in patients with AD [48, 49]. In patients with pre-existing AD systemic infections will act as effective secondary infections producing stimulation of microglial cells in the brain leading to an accumulation of pathological changes in the brain and cognitive decline, resulting in acute episodes of chronic cognitive deficits (usually of short duration (less than two weeks)), such as delirium and further impairment of premorbid cognitive state, ultimately leading to emergency hospitalization of the patient [45, 47].
In our study, we temporarily did not find a short-term association between PM10 and AD admission. Previous epidemiological evidence on PM10 and AD is limited and inconsistent. A study in Rome found a negative correlation between PM10 and AD (OR = 0.95) [50]. Studies in Taiwan and Barcelona found that long-term exposure to PM10 was significantly associated with increased AD risk [51, 52]. This may mainly depend on the different results selected; most previous studies have analyzed the incidence rate of the disease as a result, while we studied emergency hospitalization caused by short-term exposure. Therefore, these results cannot be directly compared with our results. It may also be due to the different sources of environmental PM10, which may lead to differences in the admission rate with neurodegenerative diseases such as AD [53]. In conclusion, due to the differences in the regression model, observation period, population exposure model, auxiliary factor set and exposure type (long-term and short-term) used in the analysis, whether short-term exposure to PM10 will increase the risk of AD hospitalization remains to be further verified. Previous studies have found that short-term exposure to high-intensity ultra-fine PM is related to the development of AD [22], and the harmful effects of PM2.5 have been confirmed in our study. We agree that PM2.5 exposure is the main contributor to AD acute hospitalization. Compared with PM10, PM2.5 is actually more toxic than PM10, because it is easy to inhale [54, 55]. This research result has important public health significance for the control of environmental micro-particle pollution.
In addition, it was also confirmed that the association between PM2.5 and AD remained significant after the introduction of a second pollutant to the single-pollutant model, with a slight increase in effect, suggesting the possible independent relationship between airborne PM2.5 and AD HAs risk. It is noteworthy that the association was even more significant after NO2 adjustment in the two-pollutant model, especially in the PM2.5 model. The sensitivity to NO2 adjustment may be due to the fact that PM and NO2 have common anthropogenic sources, such as traffic. Air pollution caused by traffic is of increasing interest to many researchers today, and several studies have found that traffic-related pollutants may contribute to neurodegenerative pathologies and become an important risk factor for AD [56,57,58].A study conducted in a highway tunnel detected higher levels of proinflammatory cytokines in the brains of mice exposed to short-term traffic-related pollution [59]. It has also been demonstrated that mice acutely exposed to diesel exhaust (DE) (250–300 μg/m3 for six hours) showed microglia activation, increased lipid peroxidation, and neuroinflammation in various brain regions (especially the hippocampus and olfactory bulb) [45]. Thus, considering the multicollinearity among air pollutants, there are still too many uncertainties [60, 61]. After adjusting CO, the relationship between PM2.5 exposure and AD inpatients became insignificant. Although AD risk rate data related to CO exposure are still limited, the epidemiologic and toxicological evidence indicated that higher concentration of CO exposure increased risks of dementia, implying that CO might have a potential impact on AD [62, 63]. Further studies are needed in the future to unravel the independent effects of air pollutants on AD.
Identifying potentially sensitive subpopulations could provide new insights into mechanisms, which has great public health significance for targeting strategies to reduce PM exposure in sensitive subpopulations. In our study, no significant difference in the effects of airborne PM pollution on the number of AD inpatients between gender groups was observed. Previous studies have been mostly limited to those of PM in relation to cognitive impairment in women [64, 65], and therefore, whether gender has an effect on this association requires further investigation. As for the analysis regarding age, elderly adults in the ≥ 85 years age group were more sensitive to airborne PM, which is consistent with results from other studies [66, 67]. A study involving 200 cities in China also found that short-term exposure to ambient PM caused an increase in daily inpatients and that elderly adults were more sensitive to PM2.5 exposure [68]. There may be multiple reasons, including APOE4 allele and autoimmune decline, for the positive association between airborne PM pollution and HAs in the senior age group population [69, 70]. In terms of the differences in season groups, we observed positive and significant associations in cold season while insignificant association was found in warm seasons, which is consistent with previous research results [71]. One possible reason for the differences is the higher PM concentrations in cold season than in warm season, people have a higher chance of exposure to PM in the cold season [72, 73]. On the other hand, PM have different toxicity profiles in different seasons due to their different varying composition, concentrations and dimensions of the PM [74]. In general, the level of particulate matter pollution in different regions, geographical locations and climatic conditions may lead to different results. More research is needed to further understand whether seasons have an impact on this relationship. From the perspective of public health, these findings are particularly useful, which have far-reaching implications for the coordinated response to the dual challenges of population aging and climate change [75].
Unfortunately, there is currently little evidence on the resource use and associated costs of AD patients in China. However, the economic burden of AD is enormous [76]. Therefore, this study determined the total number of HAs and associated economic burden of AD patients from 2017 to 2019 and identified that 16.48% of AD patients were attributable to environmental PM effects throughout the study period using the attributable risk method. The direct medical costs and indirect economic costs of HAs caused by PM exposure were US$ 2.25 million and US$ 0.31 million, respectively. The study found that particulate matter exposure can cause adverse effects such as increased economic burden of AD, which is consistent with previous studies [77]. Measuring the effects in monetary terms helps to attach great importance to air pollution from a society-wide perspective. Therefore, if effective AD prevention and control strategies can be employed starting from strengthening air pollution control, the AD HAs and associated economic burden can be largely alleviated.
We acknowledge that our current study has some limitations. First, the air pollutant concentrations in this study were derived based on residential addresses. Although the evidence on the associations of air pollutant concentrations (source: residential addresses) and a range of health outcomes has been very strong in recent years [78], our lack of consideration of workplace exposure, exposure during commuting, and exposure to indoor sources may have resulted in some exposure misclassification. This may have led to underestimated effects of short-term exposure to airborne PM on AD and thus an underestimation of the total disease burden of AD. Second, several studies have noted that the APOE4 allele significantly increases the risk of developing AD; however, APOE4 genotyping is not currently recommended in routine clinical practice. Therefore, we were unable to obtain complete data on patient-related confounders to further verify whether carriers of the APOE4 allele living in a contaminated environment are at a higher risk of developing AD [79]. Third, due to data limitations, only the direct economic burden of AD HAs attributable to PM exposure and the indirect economic burden caused by reduced productivity as a result of HAs were estimated. No other types of economic burden were considered. The indirect costs [10, 80] and intangible economic burden [81] associated with social support for AD patients have been demonstrated to be substantial, so the actual economic burden of AD may be even greater. Finally, this is an ecological study of short-term associations comparing the AD and PM. Its ecological design means that no causal relationship can be established between increases in PM concentrations and emergency AD admissions. Even so, the time series analysis methodology used in our study has been previously tried and tested in a large number of studies linking short-term exposure to atmospheric pollution to emergency hospital admissions for chronic debilitating brain disease (such as Alzheimer's disease, Parkinson's disease and other dementias) [22, 23, 44, 82,83,84,85,86]. In the future, further research is needed to reveal the health effects and underlying mechanisms of short-term exposure to PM on AD.
Conclusions
This multi-city time-series study found that short-term exposure to airborne PM2.5 may increase the risk of AD HAs after adjusting temperature and relative humidity. There is a positive association between PM2.5 exposure and the number of AD inpatients, and it was found that HAs attributable to airborne PM pollution can impose a heavy disease and financial burden on AD patients and their families. This finding has great public health significance for promoting improved ambient air quality and healthcare services in Sichuan Province, and it provides evidence for the need to reduce health inequities associated with air pollution and to make health policies related to China's rapidly aging population.
Availability of data and materials
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- RR:
-
Relative risk
- 95%CI:
-
95% Confidence interval
- PM2.5 :
-
Particulate matter ≤ 2.5 μm in aerodynamic diameter
- PM10 :
-
Particulate matter ≤ 10 μm in aerodynamic diameter
- CO:
-
Carbon monoxide
- SO2 :
-
Sulfur dioxide
- NO2 :
-
Nitrogen dioxide
- O3 :
-
Ozone
- HAs:
-
Hospital admission
- API:
-
Application programming interface
References
Porsteinsson AP, Isaacson RS, Knox S et al (2021) Diagnosis of early Alzheimer’s disease: clinical practice in 2021. J Prev Alzheimers Dis 8:371–386. https://doi.org/10.14283/jpad.2021.23
World Health Organization (2017) Global action plan on the public health response to dementia 2017–2025. World Health Organization, Geneva
World Health Organization (2021) Global status report on the public health response to dementia. World Health Organization, Geneva
Zhang Y, Li Y, Ma L (2020) Recent advances in research on Alzheimer’s disease in China. J Clin Neurosci 81:43–46. https://doi.org/10.1016/j.jocn.2020.09.018
Jia L, Du Y, Chu L et al (2020) Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health 5:e661–e671. https://doi.org/10.1016/S2468-2667(20)30185-7
Bo Z, Wan Y, Meng SS et al (2019) The temporal trend and distribution characteristics in mortality of Alzheimer’s disease and other forms of dementia in China: based on the national mortality surveillance system (NMS) from 2009 to 2015. PLoS ONE 14:e0210621. https://doi.org/10.1371/journal.pone.0210621
GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
Ren R, Qi J, Lin S et al (2022) The China Alzheimer Report 2022. Gen Psychiatry 35:e100751. https://doi.org/10.1136/gpsych-2022-100751
Livingston G, Huntley J, Sommerlad A et al (2020) Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet 396:413–446. https://doi.org/10.1016/S0140-6736(20)30367-6
Clay E, Zhou J, Yi Z-M et al (2019) Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study. J Mark Access Health Policy 7:1667195. https://doi.org/10.1080/20016689.2019.1667195
Jia L, Quan M, Fu Y et al (2020) Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol 19:81–92. https://doi.org/10.1016/S1474-4422(19)30290-X
Loera-Valencia R, Cedazo-Minguez A, Kenigsberg PA et al (2019) Current and emerging avenues for Alzheimer’s disease drug targets. J Intern Med 286:398–437. https://doi.org/10.1111/joim.12959
Underwood E (2017) The polluted brain. Science 355(6323):342–345. https://doi.org/10.1126/science.355.6323
Wang Y, Zhang M, Li Z et al (2019) Fine particulate matter induces mitochondrial dysfunction and oxidative stress in human SH-SY5Y cells. Chemosphere 218:577–588. https://doi.org/10.1016/j.chemosphere.2018.11.149
Cole TB, Coburn J, Dao K et al (2016) Sex and genetic differences in the effects of acute diesel exhaust exposure on inflammation and oxidative stress in mouse brain. Toxicology 374:1–9. https://doi.org/10.1016/j.tox.2016.11.010
Kritikos M, Gandy SE, Meliker JR et al (2020) Acute versus chronic exposures to inhaled particulate matter and neurocognitive dysfunction: pathways to Alzheimer’s disease or a related dementia. J Alzheimers Dis 78:871–886. https://doi.org/10.3233/JAD-200679
Fu P, Guo X, Cheung FMH, Yung KKL (2019) The association between PM2.5 exposure and neurological disorders: a systematic review and meta-analysis. Sci Total Environ 655:1240–1248. https://doi.org/10.1016/j.scitotenv.2018.11.218
Åström DO, Adolfsson R, Segersson D et al (2021) Local contrasts in concentration of ambient particulate air pollution (PM2.5) and incidence of Alzheimer’s disease and dementia: results from the Betula Cohort in Northern Sweden. J Alzheimers Dis 81:83–85. https://doi.org/10.3233/JAD-201538
Jung C-R, Lin Y-T, Hwang B-F (2015) Ozone, particulate matter, and newly diagnosed Alzheimer’s disease: a population-based cohort study in Taiwan. J Alzheimers Dis 44:573–584. https://doi.org/10.3233/JAD-140855
Ran J, Schooling CM, Han L et al (2021) Long-term exposure to fine particulate matter and dementia incidence: a cohort study in Hong Kong. Environ Pollut 271:116303. https://doi.org/10.1016/j.envpol.2020.116303
He F, Tang J, Zhang T et al (2022) Impact of air pollution exposure on the risk of Alzheimer’s disease in China: a community-based cohort study. Environ Res 205:112318. https://doi.org/10.1016/j.envres.2021.112318
Culqui DR, Linares C, Ortiz C et al (2017) Association between environmental factors and emergency hospital admissions due to Alzheimer’s disease in Madrid. Sci Total Environ 592:451–457. https://doi.org/10.1016/j.scitotenv.2017.03.089
Franco P, Gordo C, Marques da Costa E, Lopes A (2023) Short-term exposure to particulate matter and effects on emergency hospital admissions for Alzheimer’s disease and Parkinson’s disease: an ecological study from an aged European metropolis. Air Qual Atmosphere Health 16:1619–1631. https://doi.org/10.1007/s11869-023-01359-4
Ning G, Wang S, Yim SHL, et al (2018) Impact of low-pressure systems on winter heavy air pollution in the northwest Sichuan Basin, China. Aerosols/field measurements/troposphere/physics (physical properties and processes).
Feng X, Liu C, Fan G et al (2016) Climatology and structures of southwest vortices in the NCEP climate forecast system reanalysis. J Clim 29:7675–7701. https://doi.org/10.1175/JCLI-D-15-0813.1
Yang W, Xie S, Zhang Z et al (2019) Characteristics and sources of carbonaceous aerosol across urban and rural sites in a rapidly urbanized but low-level industrialized city in the Sichuan Basin, China. Environ Sci Pollut Res 26:26646–26663. https://doi.org/10.1007/s11356-019-05242-7
Jiang W, Chen H, Liao J et al (2022) The short-term effects and burden of particle air pollution on hospitalization for coronary heart disease: a time-stratified case-crossover study in Sichuan. China Environ Health 21:19. https://doi.org/10.1186/s12940-022-00832-4
Szyszkowicz M (2019) Case-crossover method with a short time-window. Int J Environ Res Public Health 17:202. https://doi.org/10.3390/ijerph17010202
Ravindra K, Rattan P, Mor S, Aggarwal AN (2019) Generalized additive models: building evidence of air pollution, climate change and human health. Environ Int 132:104987. https://doi.org/10.1016/j.envint.2019.104987
Zhang Y, Ebelt ST, Shi L et al (2023) Short-term associations between warm-season ambient temperature and emergency department visits for Alzheimer’s disease and related dementia in five US states. Environ Res 220:115176. https://doi.org/10.1016/j.envres.2022.115176
Gao X, Jiang W, Liao J et al (2022) Attributable risk and economic cost of hospital admissions for depression due to short-exposure to ambient air pollution: a multi-city time-stratified case-crossover study. J Affect Disord 304:150–158. https://doi.org/10.1016/j.jad.2022.02.064
Alzheimer’s Association Report (2021) 2021 Alzheimer’s disease facts and figures Alzheimer’s dementia. J Alzheimer’s Assoc 17(3):327–406. https://doi.org/10.1002/alz.12328
Riedel BC, Thompson PM, Brinton RD (2016) Age, APOE and sex: triad of risk of Alzheimer’s disease. J Steroid Biochem Mol Biol 160:134–147. https://doi.org/10.1016/j.jsbmb.2016.03.012
Wine O, Osornio Vargas A, Campbell SM et al (2022) Cold climate impact on air-pollution-related health outcomes: a scoping review. Int J Environ Res Public Health 19:1473. https://doi.org/10.3390/ijerph19031473
Altman DG (2003) Statistics notes: interaction revisited: the difference between two estimates. BMJ 326:219–219. https://doi.org/10.1136/bmj.326.7382.219
Zeka A, Zanobetti A, Schwartz J (2006) Individual-level modifiers of the effects of particulate matter on daily mortality. Am J Epidemiol 163:849–859. https://doi.org/10.1093/aje/kwj116
Zhang P, Zhou X (2020) Health and economic impacts of particulate matter pollution on hospital admissions for mental disorders in Chengdu Southwestern China. Sci Total Environ 733:139114. https://doi.org/10.1016/j.scitotenv.2020.139114
Tian Y, Liu H, Liang T et al (2018) Ambient air pollution and daily hospital admissions: a nationwide study in 218 Chinese cities. Environ Pollut 242:1042–1049. https://doi.org/10.1016/j.envpol.2018.07.116
Gasparrini A, Leone M (2014) Attributable risk from distributed lag models. BMC Med Res Methodol 14:55. https://doi.org/10.1186/1471-2288-14-55
WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide. https://apps.who.int/iris/handle/10665/345329?search-result=true&query=WHO+global++air+quality++guidelines&scope=&rpp=10&sort_by=score&order=desc. Accessed 19 Sep 2022.
Sylvestre M-P, Abrahamowicz M (2009) Flexible modeling of the cumulative effects of time-dependent exposures on the hazard. Stat Med 28:3437–3453. https://doi.org/10.1002/sim.3701
Wannemuehler KA, Lyles RH, Waller LA et al (2009) A conditional expectation approach for associating ambient air pollutant exposures with health outcomes. Environmetrics 20:877–894. https://doi.org/10.1002/env.978
Heusinkveld HJ, Wahle T, Campbell A et al (2016) Neurodegenerative and neurological disorders by small inhaled particles. Neurotoxicology 56:94–106. https://doi.org/10.1016/j.neuro.2016.07.007
Yitshak-Sade M, Nethery R, Schwartz JD et al (2021) PM2.5 and hospital admissions among medicare enrollees with chronic debilitating brain disorders. Sci Total Environ 755:142524. https://doi.org/10.1016/j.scitotenv.2020.142524
Costa LG, Cole TB, Coburn J et al (2017) Neurotoxicity of traffic-related air pollution. Neurotoxicology 59:133–139. https://doi.org/10.1016/j.neuro.2015.11.008
Roqué PJ, Dao K, Costa LG (2016) Microglia mediate diesel exhaust particle-induced cerebellar neuronal toxicity through neuroinflammatory mechanisms. Neurotoxicology 56:204–214. https://doi.org/10.1016/j.neuro.2016.08.006
Holmes C, El-Okl M, Williams AL et al (2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 74:788–789. https://doi.org/10.1136/jnnp.74.6.788
Godbout JP, Chen J, Abraham J et al (2005) Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J Off Publ Fed Am Soc Exp Biol 19:1329–1331. https://doi.org/10.1096/fj.05-3776fje
Palin K, Cunningham C, Forse P et al (2008) Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration. Neurobiol Dis 30:19–29. https://doi.org/10.1016/j.nbd.2007.11.012
Cerza F, Renzi M, Gariazzo C et al (2019) Long-term exposure to air pollution and hospitalization for dementia in the Rome longitudinal study. Environ Health 18:72. https://doi.org/10.1186/s12940-019-0511-5
Crous-Bou M, Gascon M, Gispert JD et al (2020) Impact of urban environmental exposures on cognitive performance and brain structure of healthy individuals at risk for Alzheimer’s dementia. Environ Int 138:105546. https://doi.org/10.1016/j.envint.2020.105546
Wu Y, Lin Y, Yu H et al (2015) Association between air pollutants and dementia risk in the elderly. Alzheimers Dement Diagn Assess Dis Monit 1:220–228. https://doi.org/10.1016/j.dadm.2014.11.015
van Wijngaarden E, Rich DQ, Zhang W et al (2021) Neurodegenerative hospital admissions and long-term exposure to ambient fine particle air pollution. Ann Epidemiol 54:79-86.e4. https://doi.org/10.1016/j.annepidem.2020.09.012
Pryor JT, Cowley LO, Simonds SE (2022) The physiological effects of air pollution: particulate matter. Physiol Dis Front Public Health 10:882569. https://doi.org/10.3389/fpubh.2022.882569
Thangavel P, Park D, Lee Y-C (2022) Recent insights into particulate matter (PM2.5)-mediated toxicity in humans: an overview. Int J Environ Res Public Health 19:7511. https://doi.org/10.3390/ijerph19127511
Woodward NE, Finch CE, Morgan T, Davis School of Gerontology and the Dornsife College, Department of Biological Sciences, University of Southern California, 3715 McClintock Ave, Los Angeles CA 9009-0191, USA (2015) Traffic-related air pollution and brain development. AIMS Environ Sci 2:353–373. https://doi.org/10.3934/environsci.2015.2.353
Woodward NC, Pakbin P, Saffari A et al (2017) Traffic-related air pollution impact on mouse brain accelerates myelin and neuritic aging changes with specificity for CA1 neurons. Neurobiol Aging 53:48–58. https://doi.org/10.1016/j.neurobiolaging.2017.01.007
Thomson EM (2019) Air pollution, stress, and allostatic load: linking systemic and central nervous system impacts. J Alzheimers Dis 69:597–614. https://doi.org/10.3233/JAD-190015
Bos I, De Boever P, Emmerechts J et al (2012) Changed gene expression in brains of mice exposed to traffic in a highway tunnel. Inhal Toxicol 24:676–686. https://doi.org/10.3109/08958378.2012.714004
Liu H, Tian Y, Xiang X et al (2018) Ambient particulate matter concentrations and hospital admissions in 26 of china’s largest cities: a case-crossover study. Epidemiology 29:649–657. https://doi.org/10.1097/EDE.0000000000000869
Solimini A, Renzi M (2017) Association between air pollution and emergency room visits for atrial fibrillation. Int J Environ Res Public Health 14:661. https://doi.org/10.3390/ijerph14060661
Chang K-H, Chang M-Y, Muo C-H et al (2014) Increased risk of dementia in patients exposed to nitrogen dioxide and carbon monoxide: a population-based retrospective cohort study. PLoS ONE 9:e103078. https://doi.org/10.1371/journal.pone.0103078
Queiroga CSF, Vercelli A, Vieira HLA (2015) Carbon monoxide and the CNS: challenges and achievements: CO and CNS. Br J Pharmacol 172:1533–1545. https://doi.org/10.1111/bph.12729
Petkus AJ, Younan D, Wang X et al (2021) Associations between air pollution exposure and empirically derived profiles of cognitive performance in older women. J Alzheimers Dis 84:1691–1707. https://doi.org/10.3233/JAD-210518
Weuve J, Puett RC, Schwartz J et al (2012) Exposure to particulate air pollution and cognitive decline in older women. Arch Intern Med 172:219–227. https://doi.org/10.1001/archinternmed.2011.683
Lo Y-TC, Lu Y-C, Chang Y-H et al (2019) Air Pollution Exposure and cognitive function in Taiwanese older adults: a repeated measurement study. Int J Environ Res Public Health 16:2976. https://doi.org/10.3390/ijerph16162976
Cleland SE, Wyatt LH, Wei L et al (2022) Short-term exposure to wildfire smoke and PM2.5 and cognitive performance in a brain-training game: a longitudinal study of U.S. adults. Environ Health Perspect 130:067005. https://doi.org/10.1289/EHP10498
Tian Y, Liu H, Liang T et al (2019) Fine particulate air pollution and adult hospital admissions in 200 Chinese cities: a time-series analysis. Int J Epidemiol 48:1142–1151. https://doi.org/10.1093/ije/dyz106
Arranz AM, De Strooper B (2019) The role of astroglia in Alzheimer’s disease: pathophysiology and clinical implications. Lancet Neurol 18:406–414. https://doi.org/10.1016/S1474-4422(18)30490-3
Silva MVF, de Loures C, MG, Alves LCV, et al (2019) Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci 26:33. https://doi.org/10.1186/s12929-019-0524-y
Wei Y, Wang Y, Lin C-K et al (2019) Associations between seasonal temperature and dementia-associated hospitalizations in New England. Environ Int 126:228–233. https://doi.org/10.1016/j.envint.2018.12.054
Shu Z, Zhao T, Liu Y et al (2022) Impact of deep basin terrain on PM2.5 distribution and its seasonality over the Sichuan Basin Southwest China. Environ Pollut Barking Essex 300:118944. https://doi.org/10.1016/j.envpol.2022.118944
Zhai S, Zhang Y, Huang J et al (2023) Exploring the detailed spatiotemporal characteristics of PM2.5: Generating a full-coverage and hourly PM2.5 dataset in the Sichuan Basin China. Chemosphere 310:136786. https://doi.org/10.1016/j.chemosphere.2022.136786
Bergmann S, Li B, Pilot E et al (2020) Effect modification of the short-term effects of air pollution on morbidity by season: a systematic review and meta-analysis. Sci Total Environ 716:136985. https://doi.org/10.1016/j.scitotenv.2020.136985
Mavrodaris A, Mattocks C, Brayne CE (2021) Healthy ageing for a healthy planet: do sustainable solutions exist? Lancet Healthy Longev 2:e10–e11. https://doi.org/10.1016/S2666-7568(20)30067-2
Pervin T, Gerdtham U-G, Lyttkens C (2008) Societal costs of air pollution-related health hazards: a review of methods and results. Cost Eff Resour Alloc 6:19. https://doi.org/10.1186/1478-7547-6-19
Kriit HK, Forsberg B, Åström DO, Oudin A (2021) Annual dementia incidence and monetary burden attributable to fine particulate matter (PM2.5) exposure in Sweden. Environ Health Glob Access Sci Sour 20:65. https://doi.org/10.1186/s12940-021-00750-x
Yin P, Brauer M, Cohen AJ et al (2020) The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990–2017: an analysis for the Global Burden of Disease Study 2017. Lancet Planet Health 4:e386–e398. https://doi.org/10.1016/S2542-5196(20)30161-3
Calderón-Garcidueñas L, Solt AC, Henríquez-Roldán C et al (2008) Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid β-42 and α-synuclein in children and young adults. Toxicol Pathol 36:289–310. https://doi.org/10.1177/0192623307313011
Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q (2022) The humanistic and economic burden of Alzheimer’s disease. Neurol Ther 11:525–551. https://doi.org/10.1007/s40120-022-00335-x
Lomas J, Schmitt L, Jones S et al (2016) A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study. BMJ Open 6:e010686. https://doi.org/10.1136/bmjopen-2015-010686
Linares C, Culqui D, Carmona R et al (2017) Short-term association between environmental factors and hospital admissions due to dementia in Madrid. Environ Res 152:214–220. https://doi.org/10.1016/j.envres.2016.10.020
Zanobetti A, Dominici F, Wang Y, Schwartz JD (2014) A national case-crossover analysis of the short-term effect of PM2.5 on hospitalizations and mortality in subjects with diabetes and neurological disorders. Environ Health 13:38. https://doi.org/10.1186/1476-069X-13-38
Lee H, Myung W, Kim DK et al (2017) Short-term air pollution exposure aggravates Parkinson’s disease in a population-based cohort. Sci Rep 7:44741. https://doi.org/10.1038/srep44741
Wei Y, Wang Y, Di Q et al (2019) Short term exposure to fine particulate matter and hospital admission risks and costs in the Medicare population: time stratified, case crossover study. BMJ 367:l6258. https://doi.org/10.1136/bmj.l6258
Goria S, Pascal M, Corso M, Le Tertre A (2021) Short-term exposure to air pollutants increases the risk of hospital admissions in patients with Parkinson’s disease—a multicentric study on 18 French areas. Atmos Environ 264:118668. https://doi.org/10.1016/j.atmosenv.2021.118668
Acknowledgements
We thank the responsible person of local medical institutions, all participants and the staff of data reduction for their cooperation.
Funding
This study was supported by the Calculation and Research of Total Health Expenditure in Sichuan Province in 2021 (No.301021002), the research projects of "Xinglin Scholars" Nursery Talent in 2021 (No.MPRC2021013) of Chengdu University of Traditional Chinese Medicine,and Chengdu Key Research Base of Philosophy and Social Sciences and Healthy City Development Research Center in 2022 (No.2022ZC005).
Author information
Authors and Affiliations
Contributions
YH, XY, and XG were major contributors in collecting the data. XY initiated the idea for the study and was involved in writing of the original draft. WJ, XY, CL and JZ developed the formal analysis and software. LY was involved in reviewing and editing. LY was the PI for the fund and designed ideas of research. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki. This study was approved by the Ethics Committee of Hospital of Chengdu University of Traditional Chinese Medicine (approval no. 2020KL-001).
Competing interests
No financial or non-financial interests have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no competing interests to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1: Table S1.
RR (95% CI) of stratified analyses for each air pollutant in the single-pollutant model PM2.5 fine particulate matter, PM10 inhalable particulate matter. Table S2. Test of interaction between subgroups. Table S3. Association between air pollutants (10 µg/m3 increase) and the daily hospitalization with AD by degrees of freedom per year. Table S4. Associations between air pollutants (every 10 µg/m3 increase in the later period of retention) and hospitalization in Alzheimer’s disease (Eliminate the data from the home address to the monitoring station greater than 50 km).
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yang, X., Jiang, W., Gao, X. et al. Impact of airborne particulate matter exposure on hospital admission for Alzheimer's disease and the attributable economic burden: evidence from a time-series study in Sichuan, China. Environ Sci Eur 36, 12 (2024). https://doi.org/10.1186/s12302-023-00833-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12302-023-00833-1